Kiniksa Pharmaceuticals International (KNSA) Earnings Date & Reports

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

KNSA is expected to report earnings to fall 215.00% to 13 cents per share on May 06

Kiniksa Pharmaceuticals International KNSA Stock Earnings Reports

Q1'25

Est.

$0.14

Q4'24

Missed

by $0.14

Q3'24

Missed

by $0.19

Q2'24

Beat

by $0.02

Q1'24

Missed

by $0.11

The last earnings report on February 25 showed earnings per share of -11 cents, missing the estimate of 1 cents. With 351.30K shares outstanding, the current market capitalization sits at 1.41B.

View a ticker or compare two or three

Compare

KNSA